RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: nose disease
Accession: DOID:2825
browse the term
Definition: Disorders of the nose, general or unspecified.
Synonyms: exact_synonym: Nasal Diseases; Nasal Disorder; disorder of the nose; nasal disease; nasal disorders; nose diseases
primary_id: MESH:D009668
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABCB1
ATP binding cassette subfamily B member 1
severity
ISO
DNA:snp:exon:c.1236C>T (human)
RGD
PMID:24040855
RGD:8657076
NCBI chr 7:79,497,536...79,706,277
Ensembl chr 7:93,147,950...93,243,238
G
ACE
angiotensin I converting enzyme
no_association
ISO
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:15112973
RGD:8142345
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
BCL2
BCL2 apoptosis regulator
ISO
mRNA, protein:increased expression:nasal mucosa (rat)
RGD
PMID:15362690
RGD:11522724
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29028686
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL26
C-C motif chemokine ligand 26
ISO
protein:increased expression:oronasal secretion (human)
RGD
PMID:23883806
RGD:7364793
NCBI chr 7:68,230,804...68,251,369
Ensembl chr 7:82,221,846...82,242,874
G
CD40
CD40 molecule
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CD40LG
CD40 ligand
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chr X:125,776,138...125,788,820
Ensembl chr X:136,042,849...136,058,202
G
CLDN3
claudin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
Ensembl chr 7:80,924,731...80,925,393
G
CLDN7
claudin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr17:7,289,766...7,292,433
Ensembl chr17:7,277,313...7,281,859
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
RGD
PMID:10436391
RGD:11344920
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:nasal mucus
RGD
PMID:21711961
RGD:5147783
NCBI chr11:46,669,925...46,690,391
Ensembl chr11:47,227,891...47,249,157
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr 5:148,879,996...149,206,914
Ensembl chr 5:154,879,080...155,204,660
G
GRIA2
glutamate ionotropic receptor AMPA type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chr 4:149,566,563...149,712,135
Ensembl chr 4:161,380,933...161,524,376
G
HRH1
histamine receptor H1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23333628
NCBI chr 3:11,074,451...11,199,871
Ensembl chr 3:11,541,294...11,542,757
G
IFNG
interferon gamma
treatment
ISO
associated with Asthma
RGD
PMID:12787306 PMID:18510219
RGD:10755770 RGD:7829803
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:23253209 PMID:23883806
RGD:7364793 RGD:7364818
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL13
interleukin 13
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human)
OMIM CTD RGD
PMID:12928861
RGD:8549516
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
protein:increased expression:serum
RGD
PMID:21462799
RGD:8549521
NCBI chr X:104,092,993...104,146,062
Ensembl chr X:114,597,077...114,635,253
G
IL17A
interleukin 17A
susceptibility
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human) DNA:snp:promoter:c.-444A>G (human)
RGD
PMID:21535180 PMID:22507625
RGD:5147409 RGD:9068429
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL18
interleukin 18
no_association severity
ISO
DNA:SNP:promoter:-140C>G (rs360721) (human) DNA:SNP:promoter:-137G>C (rs187238) (human)
RGD
PMID:22840759
RGD:8655914
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:nasal mucus
RGD
PMID:7750009
RGD:7401199
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL2
interleukin 2
ISO
RGD
PMID:12592663
RGD:8662963
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:8908280 PMID:9893928 PMID:14653048 PMID:24620662
RGD:11522769 RGD:7829796 RGD:7829802 RGD:7829827
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL5
interleukin 5
treatment
ISO
RGD
PMID:23934070 PMID:24620662
RGD:11354976 RGD:11522769
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
G
ITGB2
integrin subunit beta 2
treatment
ISO
RGD
PMID:12046991
RGD:9698435
NCBI chr21:31,181,228...31,216,033
Ensembl chr21:44,470,999...44,505,963
G
MUC1
mucin 1, cell surface associated
severity
ISO
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:31425778
RGD:127345100
NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:22972875
RGD:7364746
NCBI chr11:1,191,223...1,234,373
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:23858718
RGD:8547523
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
OCLN
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chr 5:44,447,230...44,509,637
Ensembl chr 5:46,023,437...46,069,342
G
PON1
paraoxonase 1
severity
ISO
protein:decreased activity:plasma (human)
RGD
PMID:23406590
RGD:8547583
NCBI chr 7:87,253,476...87,279,650
Ensembl chr 7:100,841,286...100,867,493
G
PRKG1
protein kinase cGMP-dependent 1
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:24012634
RGD:7775060
NCBI chr10:47,642,312...48,935,188
Ensembl chr10:49,779,211...51,064,882
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16979129
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
SCGB1A1
secretoglobin family 1A member 1
ISO
mRNA:decreased expression:nasal mucosa, lung
RGD
PMID:17882576
RGD:5144135
NCBI chr11:57,774,560...57,780,334
Ensembl chr11:61,133,649...61,137,873
G
SCGB3A2
secretoglobin family 3A member 2
susceptibility
ISO
DNA:SNP: :rs7726552 (human)
RGD
PMID:21410962
RGD:5144225
NCBI chr 5:143,319,941...143,323,625
Ensembl chr 5:149,329,201...149,333,003
G
SERPINE1
serpin family E member 1
ISO
mRNA:increased expression:nasal mucosa (mouse)
RGD
PMID:21339035
RGD:8547809
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
TACR1
tachykinin receptor 1
ISO
mRNA:increased expression:nasal mucosa
RGD
PMID:12768696
RGD:5147835
NCBI chr2A:75,111,339...75,267,320
Ensembl chr2A:76,614,478...76,771,018
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:31368266
RGD:14995445
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TLR2
toll like receptor 2
severity
ISO
mRNA:decreased expression:nasal mucosa: DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil:
RGD
PMID:18219831 PMID:18381801 PMID:22402138 PMID:22555057
RGD:7800732 RGD:7800742 RGD:8552972 RGD:8552993
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
susceptibility no_association treatment severity
ISO
protein:increased expression:nasal lavage,leukocyte, bone marrow: DNA:SNP: :rs1927911(human) protein:decreased expression:nasal mucosa: DNA:polymorphism: :4216G>C(human) DNA:polymorphism:cds:p.D299G(human)
RGD
PMID:17069098 PMID:19763595 PMID:22402138 PMID:22555057 PMID:22577387 PMID:23639307 More...
RGD:4145354 RGD:7800732 RGD:7800736 RGD:7800738 RGD:7800740 RGD:8552993
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
treatment
ISO
associated with Eosinophilic Esophagitis; DNA:polymorphisms::
RGD
PMID:26416193
RGD:11352743
NCBI chr10:91,375,255...91,465,215
Ensembl chr10:94,884,472...94,970,065
G
IL3
interleukin 3
susceptibility
ISO
DNA:SNP: :rs40401(human)
RGD
PMID:23953855
RGD:13506915
NCBI chr 5:127,483,843...127,486,388
Ensembl chr 5:133,647,667...133,650,213
G
SMCHD1
structural maintenance of chromosomes flexible hinge domain containing 1
ISO
ClinVar Annotator: match by term: Arhinia, choanal atresia, and microphthalmia
OMIM ClinVar
PMID:672092 PMID:5032329 PMID:6802865 PMID:8446727 PMID:8723126 PMID:11321738 PMID:16353241 PMID:23143600 PMID:23432817 PMID:23852095 PMID:25741868 PMID:26440771 PMID:26467025 PMID:26842768 PMID:28067909 PMID:28067911 PMID:28492532 PMID:31243061 PMID:31312724 More...
NCBI chr18:11,479,742...11,627,035
Ensembl chr18:13,785,912...13,933,887
G
LOC100987081
HLA class II histocompatibility antigen, DR alpha chain
susceptibility
ISO
DNA:SNPs,haplotype:introns:
RGD
PMID:22391069
RGD:13506908
NCBI chr 6:32,105,421...32,110,579
Ensembl chr 6:32,982,228...32,987,417
G
TBX21
T-box transcription factor 21
ISO
ClinVar Annotator: match by term: Asthma and nasal polyps
ClinVar
PMID:15806396
NCBI chr17:9,791,008...9,803,894
Ensembl chr17:9,973,920...9,985,660
G
ALOX15
arachidonate 15-lipoxygenase
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:17959182 PMID:21558275 PMID:30643255
NCBI chr17:4,686,339...4,696,877
Ensembl chr17:4,677,125...4,687,669
G
PTGER2
prostaglandin E receptor 2
ISO
OMIM
NCBI chr14:32,910,755...32,926,138
Ensembl chr14:51,195,381...51,209,686
G
TBX21
T-box transcription factor 21
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
OMIM ClinVar
PMID:25741868
NCBI chr17:9,791,008...9,803,894
Ensembl chr17:9,973,920...9,985,660
G
FREM1
FRAS1 related extracellular matrix 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23221805
NCBI chr 9:14,567,781...14,748,474
Ensembl chr 9:15,081,208...15,253,399
G
ADNP2
ADNP homeobox 2
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:73,757,926...73,789,771
Ensembl chr18:77,080,441...77,103,098
G
ATP9B
ATPase phospholipid transporting 9B (putative)
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:72,468,421...72,847,314
Ensembl chr18:75,686,430...75,988,106
G
CTDP1
CTD phosphatase subunit 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:73,279,510...73,357,718
Ensembl chr18:76,646,641...76,722,573
G
GALR1
galanin receptor 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:70,643,718...70,664,068
Ensembl chr18:73,899,995...73,917,752
G
HSBP1L1
heat shock factor binding protein 1 like 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:73,608,483...73,615,823
G
KCNG2
potassium voltage-gated channel modifier subfamily G member 2
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:73,431,735...73,546,602
G
MBP
myelin basic protein
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:70,369,882...70,526,693
Ensembl chr18:73,629,522...73,755,351
G
NFATC1
nuclear factor of activated T cells 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:72,948,067...73,083,180
Ensembl chr18:76,017,454...76,094,453
G
PARD6G
par-6 family cell polarity regulator gamma
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:73,806,710...73,904,494
Ensembl chr18:77,122,483...77,167,659
G
RBFA
ribosome binding factor A
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:73,679,972...73,696,321
Ensembl chr18:76,997,888...77,013,864
G
SALL3
spalt like transcription factor 3
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:72,381,249...72,403,789
G
SLC66A2
solute carrier family 66 member 2
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:73,549,273...73,596,658
G
TXNL4A
thioredoxin like 4A
ISO
ClinVar Annotator: match by term: Bilateral choanal atresia, cardiac defects, deafness, and dysmorphic appearance | ClinVar Annotator: match by term: Burn-McKeown syndrome
OMIM ClinVar
PMID:1342861 PMID:14564154 PMID:16523509 PMID:25434003 PMID:25741868 PMID:28492532 PMID:34713892 More...
NCBI chr18:73,618,302...73,679,603
Ensembl chr18:76,937,460...76,952,428
G
ZNF236
zinc finger protein 236
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:70,213,383...70,361,741
Ensembl chr18:73,496,761...73,617,956
G
ZNF516
zinc finger protein 516
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chr18:69,748,472...69,891,026
Ensembl chr18:73,026,076...73,103,609
G
KMT2D
lysine methyltransferase 2D
ISO
ClinVar Annotator: match by term: Choanal atresia
ClinVar
PMID:25741868 PMID:31395954
NCBI chr12:39,689,463...39,731,904
Ensembl chr12:40,575,083...40,608,661
G
PTPN14
protein tyrosine phosphatase non-receptor type 14
ISO
ClinVar Annotator: match by term: Choanal atresia and lymphedema
OMIM ClinVar
PMID:20826270 PMID:25741868
NCBI chr 1:189,925,706...190,120,232
Ensembl chr 1:194,780,068...194,887,798
G
EDN1
endothelin 1
ISO
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human)
RGD
PMID:8845175
RGD:8661738
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
G
CD8A
CD8 subunit alpha
ameliorates
ISO
protein:decreased expression:blood, T cell (human)
RGD
PMID:24639246
RGD:124715444
NCBI chr2A:86,832,559...86,855,772
Ensembl chr2A:88,377,722...88,382,635
G
IL17A
interleukin 17A
ISO
protein:increased expression:uncinate process, nasal mucosa (human)
RGD
PMID:23613503
RGD:8696039
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
LOC100991079
interleukin-1 receptor antagonist protein
susceptibility
ISO
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human)
RGD
PMID:16549749
RGD:8549791
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
MBL2
mannose binding lectin 2
ISO
protein:decreased activity:serum:
RGD
PMID:23144819
RGD:8693716
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
PRG2
proteoglycan 2, pro eosinophil major basic protein
disease_progression
ISO
associated with Nasal Polyps;
RGD
PMID:24450586
RGD:13506943
NCBI chr11:52,628,289...52,631,634
Ensembl chr 3:160,118,111...160,122,002
G
ACVRL1
activin A receptor like type 1
ISO
ClinVar Annotator: match by term: Epistaxis
ClinVar
PMID:11484689 PMID:15687131 PMID:16540754 PMID:17786384 PMID:18159113 PMID:18498373 PMID:20056902 PMID:20501893 PMID:21378382 PMID:22632830 PMID:23124896 PMID:23298310 PMID:23919827 PMID:25741868 PMID:26387786 PMID:27316748 PMID:28492532 PMID:30260738 PMID:32581362 More...
NCBI chr12:36,839,869...36,856,351
Ensembl chr12:37,615,888...37,631,691
G
ENG
endoglin
ISO
ClinVar Annotator: match by term: Spontaneous, recurrent epistaxis
ClinVar
PMID:15879500 PMID:16542389 PMID:28492532 PMID:30251589
NCBI chr 9:98,934,080...98,973,862
Ensembl chr 9:127,605,608...127,644,641
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
RGD
PMID:15040115
RGD:8662355
NCBI chr 6:36,241,405...36,250,032
Ensembl chr 6:37,436,990...37,445,599
G
CLU
clusterin
ISO
RGD
PMID:19903339
RGD:9014708
NCBI chr 8:26,867,973...26,884,838
Ensembl chr 8:24,070,053...24,083,523
G
SOX2
SRY-box transcription factor 2
ISO
DNA:amplification
RGD
PMID:23544055
RGD:8661654
NCBI chr 3:178,744,881...178,747,392
Ensembl chr 3:186,922,705...186,923,662
G
TP53
tumor protein p53
ISO
RGD
PMID:19950227
RGD:8547762
NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120
G
NPY
neuropeptide Y
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9288221
NCBI chr 7:24,963,056...24,970,803
Ensembl chr 7:24,568,041...24,574,657
G
ABCB1
ATP binding cassette subfamily B member 1
ISO
associated with Chronic Rhinosinusitis;protein:increased expression:nasal sinus (human)
RGD
PMID:22223515
RGD:8657074
NCBI chr 7:79,497,536...79,706,277
Ensembl chr 7:93,147,950...93,243,238
G
ADRB2
adrenoceptor beta 2
susceptibility
ISO
DNA:polymorphism:p.R16G(human)
RGD
PMID:17621827
RGD:8548469
NCBI chr 5:144,259,756...144,398,421
Ensembl chr 5:150,267,554...150,315,892
G
ALOX12
arachidonate 12-lipoxygenase, 12S type
ISO
mRNA:decreased expression:nasal cavity epithelium
RGD
PMID:20554417
RGD:5509597
NCBI chr17:7,026,839...7,041,598
Ensembl chr17:7,014,591...7,029,602
G
ALOX15
arachidonate 15-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:nasal cavity epithelium
CTD RGD
PMID:20554417 PMID:30643255
RGD:5509597
NCBI chr17:4,686,339...4,696,877
Ensembl chr17:4,677,125...4,687,669
G
ANG
angiogenin
ISO
RGD
PMID:21711968
RGD:6892710
NCBI chr14:1,548,693...1,558,528
Ensembl chr14:19,614,950...19,615,393
G
ANXA1
annexin A1
ISO
RGD
PMID:20549082
RGD:7421567
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
BDNF
brain derived neurotrophic factor
ISO
associated with Sinusitis;protein:decreased expression:respiratory system mucosa
RGD
PMID:19958603
RGD:4891064
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
CAT
catalase
ISO
protein:increased activity:nasal concha:
RGD
PMID:16287205
RGD:9479048
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL1
C-C motif chemokine ligand 1
ISO
associated with Sinusitis
RGD
PMID:20598643
RGD:4891418
NCBI chr17:22,425,022...22,430,243
Ensembl chr17:22,719,425...22,722,341
G
CCL11
C-C motif chemokine ligand 11
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:10415058
RGD:4145448
NCBI chr17:22,495,737...22,515,144
Ensembl chr17:22,806,076...22,808,345 Ensembl chr17:22,806,076...22,808,345
G
CCL2
C-C motif chemokine ligand 2
ISO
protein:increased expression:sinus:
RGD
PMID:22287435
RGD:7483612
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCL20
C-C motif chemokine ligand 20
ISO
associated with Rhinosinusitis associated with Allergic Rhinitis
RGD
PMID:19027509 PMID:22287435
RGD:7483586 RGD:7483612
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
G
CCL24
C-C motif chemokine ligand 24
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:10415058
RGD:4145448
NCBI chr 7:68,206,688...68,210,343
Ensembl chr 7:82,263,310...82,265,480
G
CCL26
C-C motif chemokine ligand 26
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:21303604
RGD:5130929
NCBI chr 7:68,230,804...68,251,369
Ensembl chr 7:82,221,846...82,242,874
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:22287435
RGD:7483612
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR6
C-C motif chemokine receptor 6
ISO
associated with Rhinosinusitis
RGD
PMID:22287435
RGD:7483612
NCBI chr 6:165,094,563...165,109,774
Ensembl chr 6:170,069,689...170,084,779
G
CHIA
chitinase acidic
ISO
associated with Sinusitis; mRNA:increased expression:mucosa of ethmoidal sinus (human)
RGD
PMID:16871939
RGD:5024927
NCBI chr 1:113,935,888...113,965,541
Ensembl chr 1:126,381,724...126,391,909
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
associated with Sinusitis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:19178793
RGD:5134986
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
G
CYSLTR1
cysteinyl leukotriene receptor 1
ISO
protein:increased expression:nasal cavity epithelium associated with Asthma associated with Rhinitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:11591188 PMID:16689996 PMID:16739673
RGD:4783198 RGD:4848936 RGD:4889117
NCBI chr X:67,412,410...67,469,366
Ensembl chr X:77,524,455...77,525,468
G
EGR1
early growth response 1
ISO
mRNA:increased expression:nasal polyp (human)
RGD
PMID:19158123
RGD:4890001
NCBI chr 5:133,845,305...133,849,291
Ensembl chr 5:139,975,635...139,979,260
G
FAS
Fas cell surface death receptor
ISO
protein:decreased expression:nasal polyp (human)
RGD
PMID:15283292
RGD:8662435
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FGF1
fibroblast growth factor 1
ISO
RGD
PMID:16720444
RGD:8655569
NCBI chr 5:137,949,100...138,054,553
Ensembl chr 5:144,056,387...144,078,001
G
FGF2
fibroblast growth factor 2
ISO
RGD
PMID:16720444
RGD:8655569
NCBI chr 4:115,005,136...115,076,369
Ensembl chr 4:126,149,813...126,214,942
G
GSTM1
glutathione S-transferase mu 1
ISO
associated with GSTT1 null genotype:DNA:deletion: :
RGD
PMID:16550944
RGD:4142528
Ensembl chr 1:127,979,238...128,010,411
G
HGF
hepatocyte growth factor
ISO
mRNA,protein:increased expression:nasal cavity mucosa:
RGD
PMID:16982975
RGD:8548613
NCBI chr 7:73,667,618...73,738,960
Ensembl chr 7:87,327,798...87,397,811
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11593541
RGD:8547687
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IFNG
interferon gamma
ISO
protein:increased expression:nasal mucosa, tissue:
RGD
PMID:9149164
RGD:8158035
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IGF1
insulin like growth factor 1
ISO
mRNA:increased expression:nasal cavity mucosa:
RGD
PMID:18202785
RGD:8548875
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
IL10
interleukin 10
ISO
RGD
PMID:22462754
RGD:7364835
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL13
interleukin 13
ISO
associated with Rhinosinusitis;protein:increased expression:serum
RGD
PMID:23969075
RGD:8549540
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL16
interleukin 16
ISO
associated with Sinusitis
RGD
PMID:17431659
RGD:5024933
NCBI chr15:60,181,827...60,299,406
Ensembl chr15:79,122,988...79,250,861
G
IL17A
interleukin 17A
ISO
protein:increased expression:nose, serum associated with rhinitis; protein:increased expression:nasal mucosa
RGD
PMID:20506642 PMID:21091665
RGD:4889132 RGD:4889137
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL1A
interleukin 1 alpha
susceptibility
ISO
associated with asthma; DNA:polymorphism:exon: DNA:SNPs:exon:
RGD
PMID:12752325 PMID:17638785
RGD:4142804 RGD:4142855
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
IL5RA
interleukin 5 receptor subunit alpha
ISO
protein:increased expression:nasal mucus, serum
RGD
PMID:12752323
RGD:5128621
NCBI chr 3:3,009,780...3,051,604
Ensembl chr 3:3,112,355...3,156,282
G
IL9
interleukin 9
ISO
associated with Bronchial Hyperreactivity
RGD
PMID:15007348
RGD:5128694
NCBI chr 5:131,283,170...131,289,777
Ensembl chr 5:137,425,367...137,428,945
G
ITGAL
integrin subunit alpha L
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11593541
RGD:8547687
NCBI chr16:24,445,966...24,496,037
Ensembl chr16:30,843,747...30,892,597
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
mRNA:decreased expression:nasal cavity epithelium
RGD
PMID:19158123
RGD:4890001
NCBI chr 1:58,042,794...58,045,536
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:inferior nasal concha:
RGD
PMID:12515274
RGD:8551781
NCBI chr 4:68,813,894...68,861,018
Ensembl chr 4:75,377,375...75,427,109
G
KITLG
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15813808
NCBI chr12:86,036,501...86,124,274
Ensembl chr12:89,341,921...89,436,758
G
LEPR
leptin receptor
ISO
mRNA:increased expression:nose
RGD
PMID:20422702
RGD:5129163
NCBI chr 1:64,772,612...64,881,886
Ensembl chr 1:66,693,926...66,764,768
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:haplotype: : HLA-DQB1*0201; associated with intrinsic asthma;DNA:polymorphism, haplotype:cds:HLA-DQB1*0202 (human)
RGD
PMID:10718431 PMID:16890076
RGD:5147813 RGD:8547658
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
LOC100977568
tenascin
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:12916355
RGD:4889591
NCBI chr 9:86,125,672...86,222,804
Ensembl chr 9:114,486,778...114,584,299
G
LOC100982859
patr class I histocompatibility antigen, B-2 alpha chain
susceptibility
ISO
DNA:polymorphisms:cds:HLA-B*07, HLA-B*57 (human, Turkish)
RGD
PMID:18922348
RGD:7364876
NCBI chr 6:31,106,562...31,109,933
Ensembl chr 6:31,997,381...32,000,067
G
MBL2
mannose binding lectin 2
ISO
associated with Sinusitis; protein:increased secretion:serum (human)
RGD
PMID:19593977
RGD:4889484
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
mRNA,protein:increased expression:nasal cavity mucosa:
RGD
PMID:16982975
RGD:8548613
NCBI chr 7:108,646,278...108,772,238
Ensembl chr 7:121,365,438...121,468,159
G
MMP1
matrix metallopeptidase 1
ISO
associated with Rhinosinusitis;mRNA:increased expression:nasal cavity mucosa
RGD
PMID:23064462
RGD:8549735
NCBI chr11:97,730,545...97,739,190
Ensembl chr11:101,221,393...101,230,104
G
MMP2
matrix metallopeptidase 2
treatment
ISO
associated with Rhinosinusitis;mRNA:increased expression:nasal cavity mucosa
RGD
PMID:21305560 PMID:23064462
RGD:8549735 RGD:8656001
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
MMP9
matrix metallopeptidase 9
susceptibility disease_progression
ISO
associated with Rhinosinusitis;mRNA:increased expression:nasal cavity mucosa associated with Asthma, Aspirin-Induced; DNA:polymorphism:promoter: -1562C>T (human)
RGD
PMID:19958602 PMID:23064462 PMID:23987197
RGD:5130861 RGD:8549735 RGD:8657056
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
ISO
RGD
PMID:15715404
RGD:7364740
NCBI chr11:1,191,223...1,234,373
G
NOS2
nitric oxide synthase 2
ISO
mRNA:increased expression:nasal mucosa DNA:repeats:promoter
RGD
PMID:18714530 PMID:20554417
RGD:4891508 RGD:5509597
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NOS3
nitric oxide synthase 3
ISO
protein:increased expression:nasal mucosa (human)
RGD
PMID:15942806
RGD:7771559
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
G
PLAUR
plasminogen activator, urokinase receptor
ISO
associated with Sinusitis
RGD
PMID:21711960
RGD:6483796
NCBI chr19:40,588,100...40,616,479
Ensembl chr19:49,197,341...49,222,561 Ensembl chr19:49,197,341...49,222,561
G
PON1
paraoxonase 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:23238704
RGD:8547666
NCBI chr 7:87,253,476...87,279,650
Ensembl chr 7:100,841,286...100,867,493
G
PPP1R9B
protein phosphatase 1 regulatory subunit 9B
ISO
associated with Chronic Rhinosinusitis;mRNA:increased expression:mucosa of paranasal sinus (human)
RGD
PMID:18391768
RGD:9999402
NCBI chr17:44,224,007...44,240,906
Ensembl chr17:49,098,089...49,126,932
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
associated with Cystic Fibrosis; protein:increased expression:nasal mucosa:
RGD
PMID:16517580
RGD:5143924
NCBI chr 9:93,495,365...93,517,557
Ensembl chr 9:121,837,095...121,859,283
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
associated with Cystic Fibrosis; protein:increased expression:nasal mucosa:
RGD
PMID:16517580
RGD:5143924
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
SOD1
superoxide dismutase 1
ISO
associated with Rhinosinusitis;protein:decreased expression:nasal mucosa: mRNA, protein:increased expression:middle nasal turbinate, lamella (human)
RGD
PMID:16540901 PMID:23921602
RGD:1581230 RGD:8547534
NCBI chr21:18,029,831...18,037,526
G
SOD2
superoxide dismutase 2
ISO
associated with Rhinosinusitis;mRNA,protein:decreased expression:nasal mucosa:
RGD
PMID:23921602
RGD:8547534
NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960
G
SOD3
superoxide dismutase 3
ISO
mRNA, protein:increased expression:middle nasal turbinate, lamella (human)
RGD
PMID:16540901
RGD:1581230
NCBI chr 4:19,195,941...19,201,298
Ensembl chr 4:24,485,059...24,485,781
G
STAT3
signal transducer and activator of transcription 3
ISO
RGD
PMID:22959364
RGD:8694314
NCBI chr17:14,928,689...15,003,644
Ensembl chr17:15,152,358...15,227,067
G
TGFB1
transforming growth factor beta 1
ISO
mRNA:decreased expression:nasal cavity epithelium associated with Rhinitis
RGD
PMID:12761968 PMID:18423831 PMID:23406597
RGD:4145277 RGD:7394830 RGD:7394852
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TLR2
toll like receptor 2
ISO
associated with Cystic Fibrosis;mRNA:increased expression:inferior nasal concha:
RGD
PMID:15836755
RGD:8552992
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
ISO
associated with Rhinosinusitis;mRNA,protein:increased expression:
RGD
PMID:23157229
RGD:7800741
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TLR7
toll like receptor 7
ISO
associated with Rhinosinusitis;mRNA,protein:increased expression:
RGD
PMID:23157229
RGD:7800741
NCBI chr X:5,479,247...5,504,810
Ensembl chr X:12,767,981...12,790,517
G
TNF
tumor necrosis factor
ISO
DNA:SNPs:promoter:
RGD
PMID:17638785
RGD:4142855
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
mRNA:decreased expression:nasal polyp (human)
RGD
PMID:19095579
RGD:5131442
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
mRNA:decreased expression:nasal polyp (human)
RGD
PMID:19095579
RGD:5131442
NCBI chr 1:10,915,743...10,957,765
Ensembl chr 1:12,130,663...12,172,646
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:Turbinates:
RGD
PMID:12761968
RGD:7394830
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
ABCB1
ATP binding cassette subfamily B member 1
severity
ISO
Nasal Type;protein:increased expression:nasal cavity (human)
RGD
PMID:18756548
RGD:8657087
NCBI chr 7:79,497,536...79,706,277
Ensembl chr 7:93,147,950...93,243,238
G
CD274
CD274 molecule
disease_progression
ISO
associated with Epstein-Barr Virus Infections
RGD
PMID:27595782
RGD:41412182
NCBI chr 9:5,269,270...5,289,629
Ensembl chr 9:5,454,391...5,474,402
G
CFLAR
CASP8 and FADD like apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15924153
NCBI chr2B:88,373,057...88,429,959
Ensembl chr2B:206,528,943...206,577,045
G
FAS
Fas cell surface death receptor
ISO
DNA:insertion, deletions:cds:multiple (human)
RGD
PMID:12466128
RGD:8662407
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
GPX3
glutathione peroxidase 3
treatment
ISO
associated with ethmoid sinus cancer and Neoplasm Metastasis
RGD
PMID:29496492
RGD:151708712
NCBI chr 5:146,447,939...146,456,476
G
JAK3
Janus kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22705984 PMID:23689514
NCBI chr19:17,299,129...17,330,700
Ensembl chr19:18,283,560...18,300,964
G
LOC100989105
signal transducer and activator of transcription 5B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29200404
NCBI chr17:15,040,303...15,116,682
Ensembl chr17:15,306,418...15,336,463
G
PRDM1
PR/SET domain 1
disease_progression
ISO
RGD
PMID:24438193
RGD:150530467
NCBI chr 6:103,899,410...103,923,389
Ensembl chr 6:107,773,229...107,796,815
G
STAT3
signal transducer and activator of transcription 3
ISO
protein:increased expression:nasal cavity (human)
RGD
PMID:17225522
RGD:153298933
NCBI chr17:14,928,689...15,003,644
Ensembl chr17:15,152,358...15,227,067
G
DMBT1
deleted in malignant brain tumors 1
ISO
mRNA, Protein:increased expression
RGD
PMID:12419858
RGD:1599782
NCBI chr10:119,129,440...119,200,232
Ensembl chr10:122,540,855...123,474,497
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16178123
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
ANXA1
annexin A1
ISO
RGD
PMID:20970165
RGD:7421559
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
ANXA2
annexin A2
disease_progression
ISO
RGD
PMID:20970165
RGD:7421559
NCBI chr15:39,322,303...39,371,565
Ensembl chr15:57,625,425...57,674,250
G
TP53
tumor protein p53
treatment
ISO
DNA:mutations:cds:
RGD
PMID:22575263 PMID:23369851
RGD:8547763 RGD:8547764
NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:decreased expression:serum
RGD
PMID:19725899
RGD:5686851
NCBI chr 3:183,876,051...183,889,723
Ensembl chr 3:192,341,320...192,354,885
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19389874
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
ISO
protein:increased expression:nasal turbinate
RGD
PMID:19364335
RGD:5147461
NCBI chr13:12,012,399...12,041,557
Ensembl chr13:30,425,510...30,476,607
G
CAT
catalase
ISO
protein:decreased expression:plasma
RGD
PMID:20493834
RGD:5130771
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL2
C-C motif chemokine ligand 2
ISO
protein:increased expression:nasal turbinate, mucosa (human)
RGD
PMID:9865755
RGD:8548839
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:Nasal Mucosa
RGD
PMID:17982926
RGD:4145109
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:17982926
RGD:4145109
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CD40
CD40 molecule
ISO
RGD
PMID:20226305
RGD:5132269
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CD86
CD86 molecule
ISO
protein:increased expression:nasal mucosa, dendritic cell (human)
RGD
PMID:17088138
RGD:4892343
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
G
CHIA
chitinase acidic
ISO
mRNA, protein:increased expression:turbinate, mucosa (human)
RGD
PMID:20422678
RGD:5037226
NCBI chr 1:113,935,888...113,965,541
Ensembl chr 1:126,381,724...126,391,909
G
EGR1
early growth response 1
ISO
DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
RGD
PMID:19833116
RGD:5131984
NCBI chr 5:133,845,305...133,849,291
Ensembl chr 5:139,975,635...139,979,260
G
F2RL1
F2R like trypsin receptor 1
ISO
RGD
PMID:17727088
RGD:4892590
NCBI chr 5:38,462,521...38,478,882
Ensembl chr 5:39,006,331...39,024,265
G
GSTP1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:17181111
RGD:4142523
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
HMOX1
heme oxygenase 1
ISO
mRNA, protein:increased expression: nasal mucosa
RGD
PMID:16540907
RGD:4145406
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased secretion:nasopharynx (human) protein:increased expression:lung, endothelium (mouse)
RGD
PMID:19047814 PMID:19968652
RGD:4145464 RGD:4145520
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IFNGR1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 6:134,958,270...134,980,560
Ensembl chr 6:139,045,821...139,068,053
G
IL13
interleukin 13
ISO
mRNA, protein:increased expression:nasal mucosa
RGD
PMID:8520776
RGD:4782826
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL17A
interleukin 17A
severity
ISO
protein:increased expression:serum
RGD
PMID:19226302
RGD:4889151
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL18
interleukin 18
susceptibility
ISO
DNA:SNP:promoter:c. -607A>C (rs1946518) (human)
RGD
PMID:16406079
RGD:4889924
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1A
interleukin 1 alpha
ISO
DNA:polymorphism:exon:c.4845G>T (human)
RGD
PMID:14533660
RGD:4142859
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
IL1R1
interleukin 1 receptor type 1
ISO
RGD
PMID:18637763
RGD:5037238
Ensembl chr2A:103,193,131...103,230,005
G
IL2
interleukin 2
ISO
protein:decreased expression:serum:
RGD
PMID:17608155
RGD:8662959
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL4
interleukin 4
treatment
ISO
protein:increased expression:serum
RGD
PMID:9237816 PMID:15329007 PMID:21171297
RGD:5128559 RGD:7829804 RGD:7829817
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL5
interleukin 5
ISO
protein: increased levels: sputum
RGD
PMID:22186238
RGD:5687140
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
G
MMP2
matrix metallopeptidase 2
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:14587983
RGD:4892078
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NOS3
nitric oxide synthase 3
ISO
DNA:snp:promoter:g.-786T>C (human)
RGD
PMID:18086269
RGD:4892054
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
protein:altered expression:nasal mucosa
RGD
PMID:20185258
RGD:4892593
NCBI chr 5:138,634,278...139,089,171
Ensembl chr 5:144,741,452...144,865,269
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
mRNA, protein:increased expression:nasal mucosa (human)
RGD
PMID:17116814
RGD:8552811
NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 9:93,495,365...93,517,557
Ensembl chr 9:121,837,095...121,859,283
G
TBXA2R
thromboxane A2 receptor
treatment
ISO
RGD
PMID:15247523
RGD:11059532
NCBI chr19:2,621,606...2,632,800
Ensembl chr19:3,570,290...3,581,924
G
ADAM33
ADAM metallopeptidase domain 33
susceptibility
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:15298558 PMID:18778489
RGD:4145378 RGD:4145383
NCBI chr20:3,750,158...3,764,262
Ensembl chr20:3,508,620...3,521,628
G
ANG
angiogenin
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr14:1,548,693...1,558,528
Ensembl chr14:19,614,950...19,615,393
G
BDKRB1
bradykinin receptor B1
ISO
RGD
PMID:12165532
RGD:5129220
NCBI chr14:76,885,923...76,894,456
G
BDKRB2
bradykinin receptor B2
ISO
RGD
PMID:1890650 PMID:11149999
RGD:4891033 RGD:4891044
NCBI chr14:76,832,833...76,873,860
Ensembl chr14:96,156,494...96,196,253
G
BDNF
brain derived neurotrophic factor
susceptibility
ISO
DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) mRNA:increased expression:nasal cavity epithelium
RGD
PMID:20464992 PMID:21723144
RGD:4891116 RGD:8655967
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
C3
complement C3
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17345707 PMID:20109314
RGD:5129524 RGD:5129539
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
C3AR1
complement C3a receptor 1
severity
ISO
protein:increased expression:nasal cavity
RGD
PMID:18538384
RGD:5129559
NCBI chr12:8,178,064...8,186,206
Ensembl chr12:8,220,933...8,222,381
G
C5AR1
complement C5a receptor 1
ISO
RGD
PMID:18538384
RGD:5129559
NCBI chr19:44,293,612...44,310,430
Ensembl chr19:52,950,317...52,966,146
G
CASP1
caspase 1
ISO
protein:increased expression:serum
RGD
PMID:12396474 PMID:20974310
RGD:5130187 RGD:5130192
NCBI chr11:99,965,964...99,975,640
Ensembl chr11:103,448,497...103,458,149 Ensembl chr11:103,448,497...103,458,149
G
CAT
catalase
treatment
ISO
protein:increased activity:blood,nasal cavity mucosa:
RGD
PMID:21541033
RGD:9479054
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL1
C-C motif chemokine ligand 1
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17982926
RGD:4145109
NCBI chr17:22,425,022...22,430,243
Ensembl chr17:22,719,425...22,722,341
G
CCL11
C-C motif chemokine ligand 11
severity
ISO
protein:increased expression:nasal mucus associated with Sinusitis;protein:increased expression:paranasal sinus
RGD
PMID:16120080 PMID:17999785
RGD:4145411 RGD:4145455
NCBI chr17:22,495,737...22,515,144
Ensembl chr17:22,806,076...22,808,345 Ensembl chr17:22,806,076...22,808,345
G
CCL17
C-C motif chemokine ligand 17
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr16:37,678,518...37,689,350
Ensembl chr16:56,819,949...56,822,131
G
CCL19
C-C motif chemokine ligand 19
ISO
RGD
PMID:17947663
RGD:5130909
NCBI chr 9:34,525,820...34,527,628
Ensembl chr 9:35,334,353...35,336,108
G
CCL22
C-C motif chemokine ligand 22
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chr16:37,631,861...37,640,208
Ensembl chr16:56,765,367...56,771,213
G
CCL24
C-C motif chemokine ligand 24
ISO
mRNA:increased expression:nasal cavity epithelium DNA:SNPs: :179T>C, 275C>T (human)
RGD
PMID:15580493 PMID:17982926
RGD:4145109 RGD:4891493
NCBI chr 7:68,206,688...68,210,343
Ensembl chr 7:82,263,310...82,265,480
G
CCL26
C-C motif chemokine ligand 26
ISO
DNA:polymorphism: :2497T>G (human) associated with Eosinophilia;protein:increased expression:oronasal secretion (human)
RGD
PMID:15580493 PMID:24989688
RGD:11531119 RGD:4891493
NCBI chr 7:68,230,804...68,251,369
Ensembl chr 7:82,221,846...82,242,874
G
CCL8
C-C motif chemokine ligand 8
ISO
RGD
PMID:20625511
RGD:5131089
NCBI chr17:22,468,080...22,470,443
Ensembl chr17:22,761,064...22,763,933
G
CCR2
C-C motif chemokine receptor 2
susceptibility
ISO
Rhinitis, Allergic, Seasonal; DNA:SNP:cds:p.V64I (human)
RGD
PMID:17135764
RGD:4145111
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR3
C-C motif chemokine receptor 3
ISO
DNA:SNP:exon:51T>C (human) mRNA:increased expression:nose protein:increased expression:blood, T cell
RGD
PMID:17135764 PMID:17156343 PMID:20696593
RGD:4145111 RGD:4145454 RGD:4145645
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
G
CD14
CD14 molecule
resistance susceptibility
ISO
DNA:polymorphism:promoter:c. -159c>T (human)
RGD
PMID:16950285 PMID:20109306
RGD:4144795 RGD:4144810
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
G
CD28
CD28 molecule
ISO
RGD
PMID:21356099
RGD:5131612
NCBI chr2B:90,938,795...90,971,438
Ensembl chr2B:209,076,388...209,111,213
G
CD80
CD80 molecule
ISO
RGD
PMID:21108691
RGD:5132622
NCBI chr 3:116,646,590...116,683,725
Ensembl chr 3:123,559,559...123,594,870
G
CDC42
cell division cycle 42
ISO
mRNA:increased expression:nasal turbinate
RGD
PMID:19432938
RGD:5688273
NCBI chr 1:21,245,970...21,286,210
G
CFTR
CF transmembrane conductance regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16083808
NCBI chr 7:109,449,847...109,633,023
Ensembl chr 7:122,129,798...122,327,864
G
CRHR1
corticotropin releasing hormone receptor 1
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr17:11,261,435...11,313,630
Ensembl chr17:11,650,057...11,701,208
G
CRHR2
corticotropin releasing hormone receptor 2
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chr 7:31,265,619...31,313,902
Ensembl chr 7:31,386,026...31,434,220
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
ISO
protein:increased expression:T cell
RGD
PMID:17625281
RGD:4891512
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:plasma
RGD
PMID:14657873
RGD:4891906
NCBI chr16:37,646,447...37,659,078
Ensembl chr16:56,779,065...56,791,760
G
CXCL6
C-X-C motif chemokine ligand 6
ISO
protein:increased expression:nasal mucus
RGD
PMID:20659080
RGD:4892030
NCBI chr 4:50,357,643...50,359,822
Ensembl chr 4:56,189,961...56,192,402
G
CYSLTR1
cysteinyl leukotriene receptor 1
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:15379985 PMID:16689996 PMID:17627772 PMID:18946234
RGD:4781451 RGD:4783198 RGD:4847512 RGD:4888516
NCBI chr X:67,412,410...67,469,366
Ensembl chr X:77,524,455...77,525,468
G
CYSLTR2
cysteinyl leukotriene receptor 2
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:16689996
RGD:4783198
NCBI chr13:29,796,598...29,853,676
Ensembl chr13:48,551,757...48,552,797
G
FCER1A
Fc fragment of IgE receptor Ia
ISO
RGD
PMID:20650300
RGD:5128714
NCBI chr 1:134,655,230...134,660,961
Ensembl chr 1:138,439,921...138,458,258
G
FIS1
fission, mitochondrial 1
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 7:93,381,058...93,386,483
Ensembl chr 7:106,621,211...106,626,683
G
HDC
histidine decarboxylase
ISO
DNA:SNP: :p.E644D (rs2073440) (human)
RGD
PMID:15054596 PMID:20608921
RGD:5128884 RGD:5143921
NCBI chr15:29,188,296...29,212,327
Ensembl chr15:47,510,629...47,534,577
G
HNMT
histamine N-methyltransferase
no_association
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17651147
RGD:5128885
NCBI chr2B:21,840,342...21,892,744
Ensembl chr2B:142,036,321...142,088,315
G
HRH1
histamine receptor H1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr 3:11,074,451...11,199,871
Ensembl chr 3:11,541,294...11,542,757
G
IL13
interleukin 13
susceptibility disease_progression
ISO
DNA:polymorphism: :rs1800925 (human) mRNA:increased expression:nose associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human)
RGD
PMID:16120094 PMID:17088137 PMID:20358028 PMID:20484924 PMID:20696593
RGD:4145454 RGD:4145534 RGD:4145767 RGD:4159171 RGD:4206706
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL13RA2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:17088137
RGD:4159171
NCBI chr X:104,092,993...104,146,062
Ensembl chr X:114,597,077...114,635,253
G
IL15
interleukin 15
ISO
RGD
PMID:16750998
RGD:5000756
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
G
IL16
interleukin 16
ISO
protein:increased expression:nasal cavity epithelium, serum protein:increased expression:serum
RGD
PMID:18254318 PMID:19295235
RGD:5024931 RGD:5024932
NCBI chr15:60,181,827...60,299,406
Ensembl chr15:79,122,988...79,250,861
G
IL17A
interleukin 17A
ISO
protein:increased expression:nasal mucosa
RGD
PMID:19927541 PMID:20506642
RGD:4889137 RGD:4889144
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL18
interleukin 18
disease_progression
ISO
protein:increased expression:serum protein:increased expression:nasal lavage fluid, bronchoalveolar lavage fluid rhinitis allergic, seasonal; protein:increased expression:plasma
RGD
PMID:15934281 PMID:17305282 PMID:17323858
RGD:4889916 RGD:4889917 RGD:4889927
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1B
interleukin 1 beta
susceptibility
ISO
associated with Hypersensitivity;protein:increased expression:nasal mucus associated with Hypersensitivity;DNA:polymorphism: :-511C>T (human) mRNA:increased expression:nasal cavity epithelium
RGD
PMID:10224452 PMID:14533660 PMID:20490816
RGD:4142821 RGD:4142859 RGD:4143227
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL2
interleukin 2
susceptibility
ISO
DNA:SNP:promoter:rs2069762(human)
RGD
PMID:16333313
RGD:8663473
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL21
interleukin 21
ISO
RGD
PMID:17982108
RGD:5147397
NCBI chr 4:114,795,979...114,806,936
Ensembl chr 4:125,943,495...125,951,915
G
IL22
interleukin 22
severity
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:21535180
RGD:5147409
NCBI chr12:65,757,069...65,762,418
Ensembl chr12:68,542,076...68,547,421
G
IL23R
interleukin 23 receptor
susceptibility
ISO
DNA:SNP,haplotype: :rs7517847(human)
RGD
PMID:23696856
RGD:8549605
NCBI chr 1:66,408,839...66,502,535
Ensembl chr 1:68,293,514...68,386,815
G
IL27RA
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:19354069
RGD:5128480
Ensembl chr19:14,323,618...14,343,627
G
IL4
interleukin 4
ISO
mRNA:increased expression:nasal cavity epithelium protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18826099 PMID:19672097 PMID:21208219
RGD:2317285 RGD:5128558
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL4R
interleukin 4 receptor
ISO
DNA:polymorphism: :c.1432T>C (human)
RGD
PMID:15564773
RGD:4890394
Ensembl chr16:27,642,702...27,737,445
G
IL5
interleukin 5
ISO
RGD
PMID:11884474
RGD:5128622
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
G
IL9
interleukin 9
ISO
RGD
PMID:20525149
RGD:5128687
NCBI chr 5:131,283,170...131,289,777
Ensembl chr 5:137,425,367...137,428,945
G
LEP
leptin
ISO
RGD
PMID:19860581
RGD:5128850
NCBI chr 7:120,230,896...120,248,602
Ensembl chr 7:132,885,011...132,901,519
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*0602 (human)
RGD
PMID:14990915
RGD:5147798
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
LOC100991079
interleukin-1 receptor antagonist protein
susceptibility
ISO
associated with Hypersensitivity associated with Hypersensitivity;DNA:repeat:intron (human)
RGD
PMID:10224452 PMID:14533660 PMID:15178892
RGD:4142859 RGD:4143215 RGD:4143227
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
MBL2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:18831943
RGD:8693717
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
MFN1
mitofusin 1
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 3:176,378,175...176,423,943
Ensembl chr 3:184,552,108...184,596,763
G
MIF
macrophage migration inhibitory factor
severity
ISO
protein:increased expression:serum, nasal mucosa
RGD
PMID:15053202 PMID:15922619
RGD:4891045 RGD:4891056
NCBI chr22:4,646,986...4,647,831
Ensembl chr22:22,730,807...22,732,009
G
MS4A2
membrane spanning 4-domains A2
ISO
RGD
PMID:15480314
RGD:5131152
NCBI chr11:55,318,843...55,326,779
Ensembl chr11:58,764,911...58,772,567
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
ISO
mRNA:increased expression:nose
RGD
PMID:15715404 PMID:20696593
RGD:4145454 RGD:7364740
NCBI chr11:1,191,223...1,234,373
G
NGF
nerve growth factor
ISO
protein:increased expression:respiratory system fluid/secretion associated with Sinusitis;protein:increased expression:respiratory system mucosa
RGD
PMID:10224365 PMID:19958603
RGD:4891064 RGD:4891115
NCBI chr 1:87,223,597...87,276,759
G
NGFR
nerve growth factor receptor
ISO
protein:increased expression:blood, eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chr17:8,089,600...8,109,361
Ensembl chr17:8,075,316...8,094,966
G
NOD1
nucleotide binding oligomerization domain containing 1
ISO
mRNA:decreased expression:nose
RGD
PMID:20384614
RGD:5131446
NCBI chr 7:31,060,245...31,109,012
Ensembl chr 7:31,182,275...31,208,742
G
NOD2
nucleotide binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:cds:2104C>T,2722G>C (human)
RGD
PMID:12704363
RGD:5131484
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:18254476
RGD:4891910
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NPY
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121
NCBI chr 7:24,963,056...24,970,803
Ensembl chr 7:24,568,041...24,574,657
G
OPA1
OPA1 mitochondrial dynamin like GTPase
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chr 3:190,890,242...190,995,133
Ensembl chr 3:201,207,607...201,312,358
G
PLAU
plasminogen activator, urokinase
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:21339035
RGD:8547809
NCBI chr10:70,433,340...70,441,569
Ensembl chr10:73,105,895...73,113,136
G
PTGDR2
prostaglandin D2 receptor 2
ISO
RGD
PMID:19230460 PMID:19608418
RGD:5135017 RGD:5135021
NCBI chr11:56,114,166...56,153,820
Ensembl chr11:59,556,460...59,557,647
G
SCGB3A2
secretoglobin family 3A member 2
ISO
protein:increased expression:sputum mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:17218572 PMID:21385388
RGD:5144232 RGD:5147389
NCBI chr 5:143,319,941...143,323,625
Ensembl chr 5:149,329,201...149,333,003
G
SERPINE1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:19063817
RGD:4144832
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
SFTPD
surfactant protein D
susceptibility
ISO
associated with Hypersensitivity;DNA:polymorphism: :p.M11T (human)
RGD
PMID:19493231
RGD:4143494
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
G
TAP1
transporter 1, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:SNPs: :
RGD
PMID:12018331 PMID:17982230
RGD:6482262 RGD:6482274
NCBI chr 6:32,414,665...32,423,488
Ensembl chr 6:33,530,171...33,538,978
G
TBXA2R
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chr19:2,621,606...2,632,800
Ensembl chr19:3,570,290...3,581,924
G
TGFB1
transforming growth factor beta 1
ISO
associated with Sinusitis
RGD
PMID:18423831
RGD:4145277
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TLR2
toll like receptor 2
no_association susceptibility
ISO
associated with Sinusitis;DNA:SNPs: :multiple (human) DNA:SNPs: :597T>C, 1350T>C (human) mRNA:decreased expression:nasal mucosa:
RGD
PMID:18219831 PMID:19128592 PMID:19763595
RGD:4145354 RGD:4145356 RGD:7800742
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR6
toll like receptor 6
ISO
associated with Asthma;DNA:SNP: :rs2381289 (human)
RGD
PMID:20815312
RGD:4145352
NCBI chr 4:33,153,151...33,174,053
Ensembl chr 4:39,009,103...39,011,490
G
TNF
tumor necrosis factor
ISO
mRNA:increased expression:nose
RGD
PMID:15120189 PMID:20696593
RGD:4143470 RGD:4145454
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
VIP
vasoactive intestinal peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121 PMID:14680090
NCBI chr 6:150,564,545...150,573,582
Ensembl chr 6:155,254,652...155,263,730
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:haplotype: :
RGD
PMID:17321882
RGD:8547664
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
ANXA1
annexin A1
ISO
associated with Nasal Polyps
RGD
PMID:22279949
RGD:7421555
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
C3
complement C3
ISO
protein:increased expression:serum
RGD
PMID:19593977
RGD:4889484
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CCL20
C-C motif chemokine ligand 20
ISO
RGD
PMID:16702571
RGD:7483585
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
G
HGF
hepatocyte growth factor
susceptibility
ISO
DNA:haplotype::rs38850,rs38855,rs38857(human)
RGD
PMID:20416453
RGD:8548615
NCBI chr 7:73,667,618...73,738,960
Ensembl chr 7:87,327,798...87,397,811
G
IGF1
insulin like growth factor 1
ISO
mRNA:increased expression:nose:
RGD
PMID:20713758
RGD:8548883
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
IL10
interleukin 10
ISO
protein:decreased expression:blood, mononuclear cell
RGD
PMID:23168151
RGD:7364820
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL17A
interleukin 17A
ISO
associated with Asthma;mRNA, protein:increased expression:nasal polyps (human)
RGD
PMID:19672092
RGD:4889146
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112
RGD:7401169
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL22RA1
interleukin 22 receptor subunit alpha 1
susceptibility
ISO
DNA:SNPs:5' utr, intron: (rs4292900, rs16829225, rs4648936) (human)
RGD
PMID:19393422
RGD:5147411
NCBI chr 1:23,322,057...23,345,557
Ensembl chr 1:24,300,902...24,324,391
G
IL4
interleukin 4
treatment
ISO
associated with Asthma
RGD
PMID:12787306
RGD:7829803
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:23401274
RGD:8547880
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
treatment
ISO
RGD
PMID:19389874 PMID:23131200
RGD:7349403 RGD:7364734
NCBI chr11:1,191,223...1,234,373
G
PRKRA
protein activator of interferon induced protein kinase EIF2AK2
severity
ISO
associated with Nasal Polyps
RGD
PMID:22961479
RGD:7777146
NCBI chr2B:65,689,029...65,708,493
Ensembl chr2B:183,393,819...183,413,174
G
SERPINE1
serpin family E member 1
ISO
protein:increased expression:nasal mucosa (human)
RGD
PMID:21711960
RGD:6483796
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
TLR2
toll like receptor 2
susceptibility
ISO
DNA:polymorphisms:: rs3804099,rs3804100(human) mRNA,protein:increased expression:paranasal sinus
RGD
PMID:21493395 PMID:22182736
RGD:7800733 RGD:8552975
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
ISO
mRNA,protein:increased expression:paranasal sinus
RGD
PMID:22182736
RGD:7800733
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112 PMID:20147558
RGD:7401169 RGD:7401236
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
ISO
DNA:polymorphisms, haplotypes:cds:HLA-DQB1*0301, HLA-DQB1*0302 (human)
RGD
PMID:15577839
RGD:5147654
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:16677242
RGD:5147463
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
G
APOA4
apolipoprotein A4
resistance
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20810159
RGD:5685642
NCBI chr11:111,659,186...111,661,790
Ensembl chr11:115,591,788...115,594,382
G
BDNF
brain derived neurotrophic factor
severity
ISO
protein:increased expression:blood, nasal cavity epithelium
RGD
PMID:18266897
RGD:5144117
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased expression:inferior turbinate, epithelium (human)
RGD
PMID:20459697
RGD:4891379
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CMA1
chymase 1
ISO
protein:increased expression:nasal mucosa, mast cell (human)
RGD
PMID:11549546
RGD:5128839
NCBI chr14:5,277,269...5,280,335
Ensembl chr14:23,400,345...23,403,548
G
FGA
fibrinogen alpha chain
ISO
RGD
PMID:21887273
RGD:5688767
NCBI chr 4:146,949,680...146,957,291
G
GSTO1
glutathione S-transferase omega 1
ISO
protein:decreased expression;T lymphocyte:
RGD
PMID:21410266
RGD:5491008
NCBI chr10:100,853,682...100,866,892
Ensembl chr10:104,313,024...104,325,733
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased secretion:nasopharynx, secretion (human)
RGD
PMID:20128420
RGD:4145459
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IFNGR1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chr 6:134,958,270...134,980,560
Ensembl chr 6:139,045,821...139,068,053
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:19505388
RGD:7365025
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL18
interleukin 18
susceptibility no_association
ISO
DNA:SNPs:promoters, exon:multiple DNA:SNPs:promoters:multiple
RGD
PMID:12532106
RGD:8655871
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL4
interleukin 4
ISO
protein:increased expression:serum mRNA:increased expression:nose:
RGD
PMID:7551298 PMID:9237816
RGD:7829817 RGD:8662960
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:nasal cavity of mucosa:
RGD
PMID:17651148
RGD:8551771
NCBI chr 4:68,813,894...68,861,018
Ensembl chr 4:75,377,375...75,427,109
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*05 (human) DNA:polymorphisms, haplotype:cds:HLA-DQB1*0301, HLA-DQB1*0501 (human)
RGD
PMID:9641569 PMID:22032123
RGD:7421561 RGD:7421576
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
MMP9
matrix metallopeptidase 9
ISO
DNA:SNPs:promoter, intron, cds:-1590C>T, 2127G>T, p.R668Q (rs3918242, rs2274755, rs17577) (human)
RGD
PMID:22237587
RGD:8547819
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
NOD1
nucleotide binding oligomerization domain containing 1
susceptibility
ISO
DNA:SNP: :rs2075817 (human)
RGD
PMID:16918516
RGD:5131519
NCBI chr 7:31,060,245...31,109,012
Ensembl chr 7:31,182,275...31,208,742
G
NOD2
nucleotide binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:5'UTR/exon, exon:rs5743266, rs2066842 (human)
RGD
PMID:16008671
RGD:5131477
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chr 9:93,495,365...93,517,557
Ensembl chr 9:121,837,095...121,859,283
G
SCGB1A1
secretoglobin family 1A member 1
ISO
mRNA, protein:decreased expression:nasal lavage fluid
RGD
PMID:15836756
RGD:5144234
NCBI chr11:57,774,560...57,780,334
Ensembl chr11:61,133,649...61,137,873
G
TLR3
toll like receptor 3
ISO
protein:decreased expression:bone marrow, blood, eosinophil (human)
RGD
PMID:19752565
RGD:5129130
NCBI chr 4:178,238,352...178,256,264
Ensembl chr 4:190,446,487...190,462,728
G
TLR4
toll like receptor 4
susceptibility
ISO
DNA:polymorphisms:cds:p.D299G, T399I (human)
RGD
PMID:18517079
RGD:4144192
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
VEGFA
vascular endothelial growth factor A
ISO
mRNA,protein:increased expression:nasal biopsies,nasal lavage fluid:
RGD
PMID:12633568
RGD:7483595
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
MAML3
mastermind like transcriptional coactivator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859338
NCBI chr 4:132,082,120...132,518,928
Ensembl chr 4:143,391,606...143,562,699
G
PAX3
paired box 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859338
NCBI chr2B:109,441,938...109,541,449
Ensembl chr2B:228,022,453...228,121,874
G
SMARCB1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
ISO
RGD
PMID:30120966
RGD:127285653
NCBI chr22:4,542,764...4,589,461
Ensembl chr22:22,627,982...22,673,921
G
CFB
complement factor B
ISO
protein:decreased expression:serum
RGD
PMID:14510109
RGD:7411729
NCBI chr 6:31,606,716...31,612,782
G
CFTR
CF transmembrane conductance regulator
susceptibility
ISO
DNA:mutations: : CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11773581 PMID:16083808
RGD:4140477
NCBI chr 7:109,449,847...109,633,023
Ensembl chr 7:122,129,798...122,327,864
G
CHIA
chitinase acidic
severity
ISO
mRNA:decreased expression:sinus, epithelial cell (human)
RGD
PMID:19379605
RGD:5037227
NCBI chr 1:113,935,888...113,965,541
Ensembl chr 1:126,381,724...126,391,909
G
CXCL5
C-X-C motif chemokine ligand 5
ISO
associated with Rhinitis;mRNA:increased expression:paranasal sinus
RGD
PMID:19153309
RGD:5135257
NCBI chr 4:50,192,665...50,195,642
Ensembl chr 4:56,024,848...56,027,989
G
IL13
interleukin 13
susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human)
CTD RGD
PMID:20358028
RGD:4145767
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL1B
interleukin 1 beta
ISO
associated with Hypersensitivity
RGD
PMID:16358839
RGD:4143214
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL2
interleukin 2
ISO
RGD
PMID:11758471
RGD:8662964
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
LOC100980965
zinc-alpha-2-glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 7:91,999,717...92,009,066
Ensembl chr 7:105,432,782...105,442,219
G
LTA
lymphotoxin alpha
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:11037831
RGD:4143260
NCBI chr 6:31,233,411...31,235,409
Ensembl chr 6:32,123,353...32,125,375
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 7:108,646,278...108,772,238
Ensembl chr 7:121,365,438...121,468,159
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression: :
RGD
PMID:20392482
RGD:5130763
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
RGD
PMID:18396779
RGD:4892328
NCBI chr 5:138,634,278...139,089,171
Ensembl chr 5:144,741,452...144,865,269
G
PDGFB
platelet derived growth factor subunit B
ISO
protein: increased expression: nasal cavity epithelium
RGD
PMID:21255638
RGD:6483060
NCBI chr22:20,127,223...20,148,407
Ensembl chr22:37,944,018...37,964,883
G
PIP
prolactin induced protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 7:135,127,479...135,135,117
G
PLAU
plasminogen activator, urokinase
ISO
RGD
PMID:21711960
RGD:6483796
NCBI chr10:70,433,340...70,441,569
Ensembl chr10:73,105,895...73,113,136
G
PLAUR
plasminogen activator, urokinase receptor
ISO
RGD
PMID:21711960
RGD:6483796
NCBI chr19:40,588,100...40,616,479
Ensembl chr19:49,197,341...49,222,561 Ensembl chr19:49,197,341...49,222,561
G
PPP1R9B
protein phosphatase 1 regulatory subunit 9B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr17:44,224,007...44,240,906
Ensembl chr17:49,098,089...49,126,932
G
SCGB3A2
secretoglobin family 3A member 2
ISO
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:21385388
RGD:5147389
NCBI chr 5:143,319,941...143,323,625
Ensembl chr 5:149,329,201...149,333,003
G
SFTPA1
surfactant protein A1
ISO
associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:17599561
RGD:4143506
NCBI chr10:76,571,312...76,575,820
G
SFTPD
surfactant protein D
ISO
associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:17599561
RGD:4143506
NCBI chr10:76,275,147...76,318,952
Ensembl chr10:78,965,252...78,974,181
G
TLR2
toll like receptor 2
ISO
mRNA:increased expression:nasal cavity epithelium:
RGD
PMID:14743629
RGD:8552991
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
ISO
associated with Pneumococal Infections; mRNA:increased expression:nasal cavity epithelium:
RGD
PMID:14743629 PMID:16301373
RGD:7800729 RGD:8552991
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all